ConductScience.org, home
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
API referenceFor AI assistants

Trial · NCT03617536

Adverse events200

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

181 to 200 of 200

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersCR845 0.25 mg Oral Tablet069
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersCR845 0.5 mg Oral Tablet066
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersCR845 1 mg Oral Tablet067
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersPlacebo Oral Tablet167
seriousHypoxiaRespiratory, thoracic and mediastinal disordersCR845 0.25 mg Oral Tablet069
seriousHypoxiaRespiratory, thoracic and mediastinal disordersCR845 0.5 mg Oral Tablet066
seriousHypoxiaRespiratory, thoracic and mediastinal disordersCR845 1 mg Oral Tablet167
seriousHypoxiaRespiratory, thoracic and mediastinal disordersPlacebo Oral Tablet067
seriousPneumonia aspirationRespiratory, thoracic and mediastinal disordersCR845 0.25 mg Oral Tablet069
seriousPneumonia aspirationRespiratory, thoracic and mediastinal disordersCR845 0.5 mg Oral Tablet166
seriousPneumonia aspirationRespiratory, thoracic and mediastinal disordersCR845 1 mg Oral Tablet067
seriousPneumonia aspirationRespiratory, thoracic and mediastinal disordersPlacebo Oral Tablet067
seriousPulmonary congestionRespiratory, thoracic and mediastinal disordersCR845 0.25 mg Oral Tablet169
seriousPulmonary congestionRespiratory, thoracic and mediastinal disordersCR845 0.5 mg Oral Tablet066
seriousPulmonary congestionRespiratory, thoracic and mediastinal disordersCR845 1 mg Oral Tablet067
seriousPulmonary congestionRespiratory, thoracic and mediastinal disordersPlacebo Oral Tablet067
seriousPulmonary oedemaRespiratory, thoracic and mediastinal disordersCR845 0.25 mg Oral Tablet169
seriousPulmonary oedemaRespiratory, thoracic and mediastinal disordersCR845 0.5 mg Oral Tablet066
seriousPulmonary oedemaRespiratory, thoracic and mediastinal disordersCR845 1 mg Oral Tablet067
seriousPulmonary oedemaRespiratory, thoracic and mediastinal disordersPlacebo Oral Tablet067

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03617536/events?page=10

API referenceFor AI assistants